EMAIL THIS PAGE TO A FRIEND

BioMed research international

Antimicrobial photodynamic therapy for methicillin-resistant Staphylococcus aureus infection.


PMID 23555074

Abstract

Nowadays methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common multidrug resistant bacteria both in hospitals and in the community. In the last two decades, there has been growing concern about the increasing resistance to MRSA of the most potent antibiotic glycopeptides. MRSA infection poses a serious problem for physicians and their patients. Photosensitizer-mediated antimicrobial photodynamic therapy (PDT) appears to be a promising and innovative approach for treating multidrug resistant infection. In spite of encouraging reports of the use of antimicrobial PDT to inactivate MRSA in large in vitro studies, there are only few in vivo studies. Therefore, applying PDT in the clinic for MRSA infection is still a long way off.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

51454
Methicillin sodium salt, ≥95% (HPLC)
C17H19N2NaO6S